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INTRODUCTION
The current novel coronavirus outbreak, which began in
December 2019 in the Wuhan region in China, represents a
massive challenge for the entire world [1]. In this era of global-
ization, illnesses, as well as information and people, travel
much more quickly today than they did even 10 years ago.
Worldwide health systems are currently under great pressure,
trying to tackle the emergency based on previous decennial ex-
perience in dealing with other infectious diseases such as an in-
fluenza epidemic.
By the end of February 2020, the coronavirus disease 2019
(COVID-2019) had spread in Northern Italy, with thousands of
patients infected with severe acute respiratory syndrome (SARS)-
CoV-2, thus requiring the Italian government to quickly intro-
duce emergency quarantine measures. Lombardy, an important
productive region in Northern Italy, was one of the most
affected, with thousands of patients who tested positive for the
virus. Consequently, almost all elective medical activity (out-
patient and surgical) was stopped. Entire hospitals were trans-
formed into COVID-19 units. In-hospital dedicated pathways
were identified. Whole new COVID-19 intensive care units (ICUs)
were created in a few days, as have new non-COVID emergency
rooms to treat urgent cases.
The emergency situation in Italy caused by the COVID-19 pan-
demic has also changed the way of treating patients requiring
cardiac surgery. The Lombardy regional government recently
introduced new rules on how to reorganize hospitals by creating
4 hubs for adult and 1 for paediatric cardiac surgery, which will
handle all emergency/urgent cases (150–200 cases/month).
This situation has never happened before in the modern era and
obviously represents a challenge in terms of rapidity and effect-
iveness of the actions needed.
As far as human resources are concerned, most of the cardiac
surgeons not working in the hub centres have been part of multi-
disciplinary teams caring for patients affected by COVID-19 in in-
ternal medicine and ICUs. Of course, being admitted to a
hospital with COVID-19 patients significantly increases the risk of
becoming infected, especially for patients with cardiovascular
disease. However, patients with cardiac emergencies/urgencies
deserve to be treated. So far, only a few papers have been pub-
lished on the COVID-19 pandemic, and even fewer have been
published on the challenges of restructuring the medical care sys-
tem under these emergency conditions.
Herein, we briefly summarize how, for the first time in Europe
since the start of the COVID-19 outbreak, the entire cardiac sur-
gery system in the North Italian region of Lombardy was modi-
fied to deal with this emergency.
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THE SARS-CoV-2
The family of coronaviruses is common across the world in ani-
mals and humans. These viruses generally are transmitted by
droplets and cause the common cold. Occasionally they are re-
sponsible for more severe diseases like the Middle East respira-
tory syndrome and the SARS, both of which often lead to
pneumonia.
The illness caused by SARS-CoV-2, a new strain of coronavirus
not previously seen in humans, has been named COVID-19
(COVID-19: CO = corona; VI = virus; D = disease; 19 = year of out-
break) [1].
Because SARS-CoV-2 is a new virus, the lack of immunity in
the population and the absence of an effective vaccine explain its
worldwide spread. On 31 December 2019, Chinese authorities
notified the World Health Organization (WHO) of an outbreak of
pneumonia in Wuhan City, which was later classified as a new
disease (named COVID-19), whereas 1 month later the WHO
declared the outbreak of COVID-19 a ‘Public Health Emergency
of International Concern’, and finally designated it a pandemic
on 11 March 2020 [2].
FROM THE CHINESE TO THE ITALIAN OUTBREAK
On 21 February 2020, Italy had its first SARS-CoV-2-positive pa-
tient. He was a 38-year-old man with no comorbidities, who
came in contact with a friend who had recently moved from
China. The patient, living in Codogno (a small town near Milan),
developed severe pneumonia requiring intubation. Then, the
Italian outbreak began.
To date, Italy has been more seriously affected than China by
COVID-19 in terms of coronavirus cases per 1 million of popula-
tion. The unexpected Italian outbreak may be explained by the
recent expansion of airline connections with China. On 8 March
2020, the Italian government announced the lockdown of the
affected regions. Two days, the quarantine was extended to the
entire country (the first in the world), as new COVID-19 cases
were detected across the country. Emergency measures included
social distancing; the suspension of community and sporting
events; and the closure of commercial activities, restaurants, edu-
cational institutes and universities.
EPIDEMIOLOGY
By 31 March 2020, Italy had 77 635 cases positive for SARS-
CoV-2; 15 729 recovered individuals and 12 428 patients killed
by the virus, with a total of 105 792 people involved (Table 1)
[3]. However, the data are changing every minute and, unfortu-
nately, they are significantly underestimated due to false-
negative testing results and the high number of paucisympto-
matic patients.
Current evidence shows that the mortality rate from
COVID-19 in Italy (10%) could be higher than the global
mortality rate of 3.4% estimated by the WHO and significantly
greater than the 0.1% from the seasonal influenza in the USA
reported by the Centers for Disease Control and Prevention
[4]. These alarming data may be partially explained by the age-
ing of the Italian population and the underestimated inci-
dence of the SARS-CoV-2 due to restrictive indications for
swab testing.
SIGNS AND SYMPTOMS
According to the US Centers for Disease Control and Prevention,
the incubation period is between 2 and 14 days [5]. Early data
show that SARS-CoV-2 could be asymptomatic or affect people
with a mild illness similar to seasonal influenza [6] but that, in
some cases pneumonia develops, with severe complications
leading to death. Dyspnoea, cough and general discomfort and
fever are the most common symptoms, whereas haemoptysis
and diarrhoea seem to be rare.
It has been reported that elderly persons infected with SARS-
CoV-2 are at increased risk for complications. Similar to the situ-
ation with seasonal influenza, underlying comorbidities (such as
obesity, hypertension and diabetes mellitus) represent important
risk factors for unfavourable outcomes [7].
Currently, neither a vaccine against SARS-CoV-2 nor any spe-
cific antiviral drug is available to defeat the infection [2].
Therefore, most therapies target symptoms and provide support
to patients with complications, and most patients treat them-
selves at home.
HUB-AND-SPOKE MODEL
On 8 March 2020, in order to deal with the COVID-19 outbreak,
the Lombardy regional government revised the entire regional
healthcare system by introducing a temporary ‘hub and spoke’
model [8].
The hub-and-spoke system is an organizational model com-
prising a network of primary anchor centres (hubs), able to pro-
vide a wide spectrum of services, and secondary satellite
establishments (spokes), which offer more limited assistance [9].
Patients in the spokes needing more intensive care are routed to
their hubs. This model provides a highly efficient organization
and enhanced quality of care. It has been used in several coun-
tries (i.e. Willis-Knighton Health System’s hub-and-spoke net-
work, Shreveport, LA, USA) and even in rural areas with
beneficial results (i.e. catheterization laboratories in the Tamil
Nadu region of India). However, some disadvantages include hub
congestion and transportation challenges.
As defined by the Lombardy ordinance, hub centres should:
1. Guarantee patient access/hospitalization by providing mul-
tiple available medical teams (with at least 1 team on active
duty 24/7).
2. Activate a ‘fast track’ for non-COVID emergency/urgent
patients, thereby avoiding COVID-19 emergency room
transit.
3. Welcome spoke teams in their respective hubs and encour-
age collaboration.
4. Ensure that patient transport is managed by the forwarding
hospital.
A decision was made to apply this model to major trauma,
stroke, emergencies/urgencies in neurosurgery, cardiovascular
surgery and interventional cardiology (in particular for acute
myocardial infarction and electrophysiological procedures). An
ordinary extracorporeal membrane oxygenation network was
maintained as well.
A mean of 150–200 adult and 50 paediatric cardiac surgical
procedures have been estimated per month in Lombardy, a re-
gion with almost 10 million inhabitants. In contrast to our usual
2 I. Belluschi et al. / European Journal of Cardio-Thoracic Surgery
D
ow
nloaded from
 https://academ
ic.oup.com
/ejcts/advance-article-abstract/doi/10.1093/ejcts/ezaa185/5841646 by U
ni M
Ilano user on 15 June 2020
practice, patients from other regions are now treated in their
own district because of transfer limitations.
Four adult and 1 paediatric cardiac surgery hubs have been
identified (Fig. 1). In the decision-making process, the following
criteria were considered for the choice of the hub centres: the
presence of dedicated 24/7 operating rooms (at least 3 simultan-
eously) and the presence of a COVID-free postoperative cardio-
vascular ICU.
LOMBARDY CARDIAC SURGERY EMERGENCY
REORGANIZATION
As a consequence of the ordinance, on 10 March 2020, the
organizers of the cardiac surgery hub centres reached a consen-
sus about the following issues:
1. Hub definitions for emergency, urgent and non-deferrable
(surgery needed within 2 months) conditions (Table 2)
were agreed on.
2. Naso- or oropharyngeal swabs must be performed pre-
operatively in all patients either in the spoke or in the hub
hospital. In addition, patients with symptoms who tested
positive for the SARS-CoV-2 needing surgery within 2
months (so-called ‘non-deferrable’) will not be operated on
whereas emergency/urgent patients with symptoms who
tested positive will be operated on (if surgery is the only
suitable therapeutic option).
3. The number of ICU beds available in each hub centre must
be declared (S. Raffaele, n = 14–20; Monzino, n = 11;
Legnano, n = 8; Brescia, n = 4–6; total n = 37/45).
4. A hub centre must have or must be provided with labora-
tory facilities for rapid diagnosis of SARS-CoV-2 (i.e. using
reverse transcription polymerase chain reaction).
5. Weekly video meetings among hub centres will be held to
share up-to-date reports.
6. Hub-and-spoke units must cooperate, particularly as relates
to the rotation of the surgical teams in case of exhausting
working shifts.
7. Transcatheter options (i.e. transcatheter aortic valve im-
plantation, percutaneous balloon aortic valvuloplasty, per-
cutaneous coronary intervention) should be considered in
non-deferrable/emergency/urgent COVID patients affected
by aortic stenosis and/or ischaemic cardiopathy.
8. Considering the limited number of ICU beds, surgical triage
must favour emergency and urgent cases.
The following issues were also considered:
• The length of hospital stay after cardiac surgery is longer than
that after percutaneous procedures. In addition, although hub
centres have to have COVID-free wards, hospital congestion
is likely to increase the risk of in-hospitals transmissions. As a
consequence, under these extraordinary circumstances, trans-
catheter options may be considered more liberally [10].
• Whenever possible, the postoperative in-hospital stay and
rehabilitation period should be reduced to a minimum,
encouraging ‘early discharge’, thereby lowering the risk of
SARS-CoV-2 transmission.
• Patients who are SARS-CoV-2 positive and who require
emergency/urgent/non-deferrable cardiac surgery have to
Table 1: Italian epidemiological situation updated on 31 March 2020 (Italian Ministry of Health data; see online version for current
up-to-date data: http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie
& p=dalministero&id=4648)
Region SARS-CoV-2 positive Discharged healed Deaths Total Naso-/oropharyngeal
swabHospitalized with symptoms ICU Quarantine Total
Lombardy 11 883 1324 11 917 25 124 10 885 7199 43 208 114 640
Emilia Romagna 3765 353 6835 10 953 1477 1644 14 074 54 532
Veneto 1680 356 5814 7850 828 477 9155 106 238
Piedmont 3174 452 4456 8082 365 854 9301 27 658
Tuscany 1120 293 2813 4226 138 244 4608 33 165
Marche 946 169 2237 3352 21 452 3825 11 724
Liguria 1153 179 1176 2508 480 428 3416 10 376
Lazio 1127 173 1342 2642 291 162 3095 34 677
Campania 501 133 1237 1871 88 133 2092 14 403
Trento 354 80 955 1389 193 164 1746 6973
Apulia 609 105 940 1654 39 110 1803 14 073
Friuli V. G. 215 60 885 1160 320 113 1593 14 899
Sicily 503 72 917 1492 74 81 1647 15 634
Abruzzo 335 73 783 1191 95 115 1401 8758
Bolzano 249 62 831 1142 153 76 1371 11 275
Umbria 176 43 632 851 190 37 1078 8685
Sardinia 113 28 516 657 34 31 722 5257
Calabria 132 17 457 606 17 36 659 9327
Aosta Valley 91 26 435 552 20 56 628 1582
Basilicata 37 17 162 216 3 7 226 2043
Molise 29 8 80 117 18 9 144 1049
Total 28 192 4023 45 420 77 635 15 729 12 428 105 792 506 968
ICU: intensive care unit; SARS: severe acute respiratory syndrome.
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Figure 1: Lombardy emergency cardiac surgery hub-and-spoke system during the coronavirus disease 2019 epidemic. This map shows the reorganization of the car-
diac surgery system for emergency and urgent situations during the coronavirus disease-2019 outbreak in Lombardy: 4 adult (A–D) hubs and 1 paediatric (E) hub
have been identified; satellite spoke centres (in numbers) are asked to transfer patients needing emergency/urgent surgery to their respective hubs.
Table 2: Definitions of emergency/urgent cardiac surgery cases adopted in Lombardy during the COVID-19 outbreak
Acute aortic syndrome 1. Acute aortic dissection/intramural haematoma (excluding patients with coma OR age >80 years with
stroke and/or evident visceral malperfusion)
2. Ascending aortic aneurysm >_6 cm
3. Ascending aortic aneurysm >_5.5 cm AND:
a. Marfan syndrome/other collagenopathy OR
b. Aneurysm increase >5 mm/year OR
c. Uncontrolled hypertension
Aortic valve 1. Severe aortic stenosis AND symptoms (i.e. lipotimia OR angina OR dyspnoea NYHA III/IV)
2. Severe aortic regurgitation AND:
a. Pulmonary oedema
b. Haemodynamic instability
Mitral valve 1. Severe mitral stenosis AND:
a. Pulmonary oedema OR
b. Haemodynamic instability
a. 2. Acute mitral insufficiency due to papillary muscle/chordal rupture leading to pulmonary oedema
Ischaemic cardiopathy 1. Unstable angina
2. Severe LMCA stenosis >_70%
3. Subocclusive proximal LAD stenosis not suitable for PCI
4. Postinfarction ventricular septal/cardiac rupture
Acute endocarditis Emergency or urgent cases (as defined by European Society of Cardiology/European Association of Cardio-
Thoracic Surgery Guidelines)
Severe bioprosthetic/mechanical
valve dysfunction
Emergency or urgent cases resulting in:
a. Heart failure OR
b. Haemodynamic instability
Heart failure Non-deferrable need for LVAD implantation
Miscellaneous 1. Cardiac tamponade
2. Atrial myxoma OR other cardiac tumours with:
a. High embolic risk OR
b. In the presence of AV valve obstruction
AV: atrioventricular; COVID-19: coronavirus disease 2019; LAD: left anterior descending; LMCA: left main coronary artery; LVAD: left ventricular assist device;
NYHA: New York Heart Association; PCI: percutaneous coronary intervention.
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be treated in a specific COVID-19 pathway, which com-
prises dedicated COVID-19 negative pressure operating
rooms, with specific protocols for cleaning; the postopera-
tive stay will be confined to COVID-ICU/wards.
Cardiovascular healthcare personnel directly involved in the
treatment of SARS-CoV-2-positive patients are required to
use specific protective equipment (i.e. FFP2/FFP3 masks),
similar to those used in COVID wards. In addition, in emer-
gency situations in which the result of swab testing is not
available at the moment of surgery (it usually takes some
hours to complete reverse transcription polymerase chain
reaction laboratory testing), it must be assumed that the pa-
tient could be SARS-CoV-2 positive; therefore, as a precau-
tion, the operation will be performed in a dedicated COVID
operating room.
• Patients who have had a recent cardiac operation are at
increased risk of acquiring the infection during the postop-
erative period despite the establishment of COVID-free
pathways. In case of novel coronavirus superinfection in the
interval after cardiac surgery, aggressive ventilation support
and early antiviral therapy should be provided.
CONCLUSIONS
The Italian COVID-19 emergency, on a scale never before seen,
represents a tremendous burden for society as a whole. The gov-
ernment quickly established quarantine measures, but the first
positive effects will only be seen after some weeks. Unfortunately,
the mortality rate seems much higher than that reported for
other countries. Further investigations are necessary to clarify the
reasons for such virulence. The entire healthcare system is facing
difficult challenges, but the introduction of a different organiza-
tion model during the COVID-19 outbreak may be extremely
helpful and should be able to satisfy all emergency needs, espe-
cially in the cardiovascular field. The results of this new network
will be determined only at the end of this pandemic. By describ-
ing the Lombardy cardiac surgery reorganization model, we are
sharing with the cardiovascular community our response to this
amazing challenge. We hope, by so doing, to be of help to other
countries facing this pandemic.
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